Post-treatment bone marrow residual disease > 5% by flow cytometry is highly predictive of short progression-free and overall survival in patients with Waldenström's macroglobulinemia.

1. García-Sanz, R.
2. Ocio, E.
3. Caballero, A.
4. Magalhães, R.J.
5. Alonso, J.
6. López-Anglada, L.
7. Villaescusa, T.
8. Puig, N.
9. Hernández, J.M.
10. Fernández-Calvo, J.
11. Aguilar, A.
12. Martín, A.
13. López, R.
14. Paiva, B.
15. Orfao, A.
16. Vidriales, B.
17. San-Miguel, J.F.
18. Del Carpio, D.